# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication, health and wellness company, an...
Truist Securities analyst Bill Chappell downgrades PetIQ (NASDAQ:PETQ) from Buy to Hold and raises the price target from $30...